2016年度　業績

循環器グループ

  1. Hasan AU, Ohmori K, Hashimoto T, Kamitori K, Yamaguchi F, Konishi K, Noma T, Igarashi J, Yamashita T, Hirano K, Tokuda M, Minamino T, Nishiyama A, Kohno M. Increase in tumor suppressor Arf compensates gene dysregulation in in vitro aged adipocytes. Biogerontology. 2017;18(1):55-68
  2. Ma J, Luo T, Zeng Z, Fu H, Asano Y, Liao Y, Minamino T, Kitakaze M. Histone Deacetylase Inhibitor Phenylbutyrate Exaggerates Heart Failure in Pressure Overloaded Mice independently of HDAC inhibition. Sci Rep. 2016;6:34036.
  3. Okuda K, Fu HY, Matsuzaki T, Araki R, Tsuchida S, Thanikachalam PV, Fukuta T, Asai T, Yamato M, Sanada S, Asanuma H, Asano Y, Asakura M, Hanawa H, Hao H, Oku N, Takashima S, Kitakaze M, Sakata Y, Minamino T. Targeted Therapy for Acute Autoimmune Myocarditis with Nano-Sized Liposomal FK506 in Rats. PLoS One. 2016;11(8):e0160944.
  4. Ito S, Asakura M, Liao Y, Min KD, Takahashi A, Shindo K, Yamazaki S, Tsukamoto O, Asanuma H, Mogi M, Horiuchi M, Asano Y, Sanada S, Minamino T, Takashima S, Mochizuki N, Kitakaze M. Identification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy. J Am Heart Assoc. 2016;5(7). pii: e003521.
  5. Masumura Y, Higo S, Asano Y, Kato H, Yan Y, Ishino S, Tsukamoto O, Kioka H, Hayashi T, Shintani Y, Yamazaki S, Minamino T, Kitakaze M, Komuro I, Takashima S, Sakata Y. Btg2 is a Negative Regulator of Cardiomyocyte Hypertrophy through a Decrease in Cytosolic RNA. Sci Rep. 2016;6:28592.
  6. Fu HY, Sanada S, Matsuzaki T, Liao Y, Okuda K, Yamato M, Tsuchida S, Araki R, Asano Y, Asanuma H, Asakura M, French BA, Sakata Y, Kitakaze M, Minamino T. Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac Dysfunction. Circ Res. 2016;118(5):798-809.
  7. Araki R, Matsuzaki T, Nakamura A, Nakatani D, Sanada S, Fu HY, OkudaK, Yamato M, Tsuchida S, Sakata Y, Minamino T.
    Development of a novel one-step production system for injectable liposomes under GMP.
    Pharm Dev Technol. 2017 Mar 20:1-6.
  8. Fu HY, Mukai M, Awata N, Sakata Y, Hori M, Minamino T.
    Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs.
    Cardiovasc Drugs Ther. 2017 Feb;31(1):109-117.

腎臓グループ

  1. Ohsaki H, Sofue T, Kawakami K, Nishijima Y, Hara T, Matsunaga T, Kushida Y, Haba R, Shigematsu Y, Irino S and Norimatsu Y. WT1 immunoenzyme staining using SurePathTM processed urine cytology helps detect kidney disease. Cytopathology 2016;27(1):43-9